In December 2018, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in December 2018 by Mayo Clinic Laboratories:
- Calmodulin-Binding Transcription Activator 1 (CAMTA1), Immunostain, Technical Component Only (Mayo ID: CAMTA)
- FosB, Immunostain, Technical Component Only (Mayo ID: BFOS)
- Retinoblastoma Protein (Rb) Immunostain, Tech Only (Mayo ID: RB1)
- Trypanosoma cruzi IgG Antibody, Lateral Flow Assay, Serum(Mayo ID: RCHAG)
In addition to these new tests, the department also announced several test changes. Click the links below to view test changes announced via Mayo Clinic Laboratories: